Company
Headquarters: Ra'anana, Israel
Employees: 10
CEO: Dr. Dror Shalitin
₪11.1 Million
ILS as of Jan. 1, 2024
US$3.1 Million
Company | Market Cap (USD) |
---|---|
Novo Nordisk | $461.52 B |
Vertex Pharmaceuticals Incorporated | $107.23 B |
Regeneron Pharmaceuticals, Inc. | $100.01 B |
CSL Limited | $94.74 B |
Marinomed Biotech AG | $73.23 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
PlantArc Bio Ltd. operates as a biotechnology company for the enhancement of crop productivity and performance for food security. The company has developed a Direct In Plant gene discovery platform. It focuses on yield and abiotic stresses, insect resistance, herbicide tolerance, and disease control market segments. The company was founded in 2014 and is based in Ra'anana, Israel.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
PlantArc Bio Ltd has the following listings and related stock indices.
Stock: TASE: PLNT wb_incandescent